Standing Committee on Plants, Animals, Food and Feed. Section Phytopharmaceuticals - Residues. 13 JUNE 2018 - 14 JUNE 20
EUROPEAN COMMISSION Health and Food Safety Directorate General
sante.ddg2.g.5(2018)3065003
Standing Committee on Plants, Animals, Food and Feed Section Phytopharmaceuticals - Residues 13 JUNE 2018 - 14 JUNE 2018 CIRCABC Link: https://circabc.europa.eu/w/browse/04e634c0-215f-4fed-b088-111101e5b42d
AGENDA
Section A
Information and/or discussion
A.01
Proposed general approach for granting transitional periods.
A.02
Art. 12 of Regulation (EC) No 396/2005 procedures: 1. Priorities under Art. 12 – updated table 2. Substances for which the Art. 12 review follows the renewal procedure 3. Confirmatory data Art. 12 follow-up: a) update of WD b) follow-up on footnotes
A.03
Dealing with non-approved basic substances.
A.04
Feedback from Legislation Committee.
A.05
Specific substances: 1. Lambda-cyhalothrin 2. Imazalil 3. Mepiquat (mushrooms) 4. Dimethoate 5. Fenpicoxamid 6. Prochloraz 7. Dimethyl-naphtalene 8. Haloxyfop-P 9. Glyphosate
10. Copper 11. Acetamiprid A.06
News from the European Food Safety Authority: 1. Progress under Article 12 of Regulation (EC) No 396/2005 2. Progress under Article 10 of Regulation (EC) No 396/2005 3. Update on Art. 43 mandates of Regulation (EC) No 396/2005 4. EFSA work programme on Art. 12 for 2018 5. EFSA opinion on food for infants and young children
A.07
EFSA Presentation of 2016 Monitoring Report and discussion on recommendations.
A.08
Project on data collection dithiocarbamates.
A.09
Honey - Technical guidelines.
A.10
State of play on cumulative risk assessment.
A.11
Work organisation for next monitoring exercise 2020, 2021, 2022.
A.12
Screening exercise on temporary MRLs in Regulation (EC) No. 396/2005 that will expire in 2018-2020. 1. Mepiquat/mushrooms 2. Difluoroacetic acid 3. Flupyradifurone 4. Chlormequat
A.13
International Matters: 1. Feedback from CCPR 2018 2. Follow-up to CCPR 2018 3. Preparations for CAC 2018 4. Principles for EU positions 5. Other International issues, e.g. OECD
A.14
Info on substances falling under the cut–off criteria in Regulation (EC) 1107/2009 and follow-up on MRL side.
A.15
Notifications under Article 18(4) to Reg. (EC) No 396/2005.
A.16
Designation of Member States for maximum residue levels (MRL) applications.
A.17
State of play of evaluation of Reg. (EC) No 396/2005 and Reg. (EC) No 1107/2009.
A.18
Update on the technical guidelines for MRL setting (SANTE/10595/2015).
A.19
Decision of the European Ombudsman in case 2000/2015/ANA on the European Commission’s compliance with the rules on the approval of plant protection products.
A.20
Info on rules of procedure Standing Committees.
A.21
Exchange of experiences with EFSA PRIMo rev. 3 (request from DE).
A.22
Preparation for Brexit.
Section B B.01
Draft(s) presented for an opinion
Exchange of views and possible opinion of the Committee on a draft Commission Regulation (EU) No …/… amending Annexes II, III and IV to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for abamectin, acibenzolar-S-methyl, clopyralid, emamectin, fenhexamid, fenpyrazamine, fluazifop-P, isofetamid, Pasteuria nishizawae Pn1, talc E533B and tebuconazole in or on certain products (Art. 10). (SANTE/10478/2018 Rev. 1) Legal Basis: Regulation (EC) No 396/2005 - Articles 5(1) and 14(1)(a) Procedure: Regulatory procedure with scrutiny
B.02
Exchange of views and possible opinion of the Committee on a draft Commission Regulation (EU) No …/… amending Annexes III and V to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for diphenylamine and oxadixyl in or on certain products (Art. 10). (SANTE/10070/2018 Rev. 1) Legal Basis: Regulation (EC) No 396/2005 - Articles 14(1)(a), 18(1)(b) and 49(2) Procedure: Regulatory procedure with scrutiny
B.03
Exchange of views and possible opinion of the Committee on a draft Commission Regulation (EU) No…/… amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for penoxsulam, triflumizole and triflumuron in or on certain products (Art.12). (SANTE/10633/2017 Rev. 2) Legal Basis: Regulation (EC) No 396/2005 - Articles 14(1)(a) and 49(2) Procedure: Regulatory procedure with scrutiny
Section C C.01
Draft(s) presented for discussion
Exchange of views of the Committee as regards maximum residue levels for bromadiolone, etofenprox, paclobutrazol, and penconazole (Art. 12). (SANTE/11715/2017) Legal Basis: Regulation (EC) No 396/2005 - Articles 14(1)(a), 18(1)(b) and 49(2) Procedure: Regulatory procedure with scrutiny
C.02
Exchange of views of the Committee as regards maximum residue levels for bromuconazole, carboxin, fenbutatin oxide, fenpyrazamine and pyridaben (Art. 12). (SANTE/10154/2018) Legal Basis: Regulation (EC) No 396/2005 - Articles 14(1)(a), 18(1)(b) and 49(2) Procedure: Regulatory procedure with scrutiny
C.03
Exchange of views of the Committee as regards maximum residue levels for bispyribac, denathonium benzoate, fenoxycarb, flurochloridone, quizalofop-P-ethyl, quizalofop-P-tefuryl, propaquizafop and tebufenozide (Art. 12). (SANTE/10482/2018) Legal Basis: Regulation (EC) No 396/2005 - Articles 14(1)(a) and 49(2) Procedure: Regulatory procedure with scrutiny
C.04
Exchange of views of the Committee as regards maximum residue levels for chlorate. (SANTE/10684/2015) Legal Basis: Regulation (EC) No 396/2005 - Articles 14(1)(a) and 16(1)(a) Procedure: Regulatory procedure with scrutiny
C.05
Exchange of views of the Committee as regards maximum residue levels for linuron. (SANTE/10145/2017) Legal Basis: Regulation (EC) No 396/2005 - Articles 14 (1)(a), 18(1)(b) and 49(2) Procedure: Regulatory procedure with scrutiny
C.06
Exchange of views of the Committee as regards maximum residue levels for iprodione. (SANTE/11836/2017) Legal Basis: Regulation (EC) No 396/2005 - Articles 14(1)(a), 18(1)(b) and 49(2) Procedure: Regulatory procedure with scrutiny
C.07
Exchange of views of the Committee as regards maximum residue levels for buprofezin, diflubenzuron, ethoxysulfuron, ioxynil, molinate, picoxystrobin and tepraloxydim. (SANTE/10151/2018) Legal Basis: Regulation (EC) No 396/2005 - Articles 14(1)(a), 18(1)(b) and 49(2) Procedure: Regulatory procedure with scrutiny
